QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification Number) | ||
|
||||
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
one-third of one redeemable warrant to purchase one share of Class A common stock |
||||
Class A common stock at an exercise price of $11.50 |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
Emerging growth company |
Item 1. | Financial Statements |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
Item 4. | Controls and Procedures |
Item 1. |
Financial Statements |
March 31, 2021 |
December 31, 2020 |
|||||||
(As Restated) |
||||||||
ASSETS |
||||||||
CURRENT ASSETS |
||||||||
Cash |
$ | $ | ||||||
Prepaid expenses |
||||||||
|
|
|
|
|||||
Total current assets |
||||||||
|
|
|
|
|||||
NONCURRENT ASSETS |
||||||||
Cash held in trust account |
— | |||||||
Derivative forward purchase agreement |
— | |||||||
|
|
|
|
|||||
Total noncurrent assets |
— | |||||||
|
|
|
|
|||||
TOTAL ASSETS |
$ | $ | ||||||
|
|
|
|
|||||
LIABILITIES, REDEEMABLE COMMON STOCK, AND STOCKHOLDERS’ DEFICIT |
||||||||
CURRENT LIABIL I TIES |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued deferred offering costs |
— | |||||||
Franchise tax payable |
— | |||||||
Note payable – related party |
— | |||||||
|
|
|
|
|||||
Total current liabilities |
||||||||
|
|
|
|
|||||
LONG-TERM LIABIL I TIES |
||||||||
Deferred underwriting commissions |
— | |||||||
Derivative warrant liabilities |
— | |||||||
|
|
|
|
|||||
Total liabilities |
||||||||
|
|
|
|
|||||
Commitments and Contingencies |
||||||||
Class A common stock subject to possible redemption; shares as of March 31, 2021 and December 31, 2020, respectively, at redemption value of $ |
— | |||||||
STOCKHOLDERS’ DEFICIT |
||||||||
Preferred stock, $ |
— | |||||||
Class A common stock, $ ( excluding ) |
— | |||||||
Class B common stock, $ |
||||||||
Additional paid-in capital |
— | |||||||
Accumulated deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total Stockholders’ Deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
TOTAL LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ DEFICIT |
$ | $ | ||||||
|
|
|
|
Three Months Ended March 31, 2021 |
||||
OPERATING EXPENSES |
||||
General and administrative expenses |
$ | |||
Franchise tax expense |
||||
|
|
|||
Total operating expenses |
( |
) | ||
|
|
|||
OTHER INCOME (EXPENSE) |
||||
Interest income on marketable securities held in Trust Account |
||||
Underwriting discounts and offering costs attributed to derivative warrant liability |
( |
) | ||
Change in fair value of derivative warrant liabilities |
||||
Change in fair value of derivative forward purchase agreement |
||||
|
|
|||
Total other income |
||||
|
|
|||
INCOME BEFORE INCOME TAX |
||||
Income tax expense (benefit) |
— | |||
|
|
|||
NET INCOME |
$ | |||
|
|
|||
Basic and diluted weighted average shares outstanding, Class A common stock |
||||
Basic and diluted net income per share, Class A common stock |
$ | |||
Basic and diluted weighted average shares outstanding, Class B common stock |
||||
Basic and diluted net income per share, Class B common stock |
$ |
Class B Common Stock |
Additional Paid-in Capital |
(Accumulated Deficit) |
Total Stockholders’ Deficit |
|||||||||||||||||
Shares |
Amount |
|||||||||||||||||||
Balance—December 31, 2020 |
$ | $ | $ | ( |
) | $ | ( |
) | ||||||||||||
Forfeiture of founder shares (1) |
( |
) | ( |
) | — | — | ||||||||||||||
Initial classification of derivative forward purchase agreement |
— | — | ( |
) | — | ( |
) | |||||||||||||
Accretion of Class A common stock subject to possible redemption |
— | — | ( |
) | ( |
) | ||||||||||||||
Net income |
— | — | — | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance—March 31, 2021 (As Restated) |
$ | $ | $ | ( |
) | $ | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
(1) | On January 29, 2021 the Sponsor forfeited |
Three Months Ended March 31, 2021 |
||||
CASH FLOWS FROM OPERATING ACTIVITIES |
||||
Net income |
$ | |||
Adjustments to reconcile net income to net cash used in operating activities: |
||||
Interest earned on cash held in Trust Account |
( |
) | ||
Underwriting discounts and offering costs attributed to warrant liability |
||||
Change in fair value of warrant liabilities |
( |
) | ||
Change in fair value of derivative forward purchase agreement |
( |
) | ||
Changes in operating assets and liabilities: |
||||
Prepaid expenses |
( |
) | ||
Accounts payable and accrued expenses |
( |
) | ||
Franchise tax payable |
||||
|
|
|||
Net cash used in operating activities |
( |
) | ||
|
|
|||
CASH FLOWS FROM INVESTING ACTIVITIES |
||||
Investment of cash in Trust Account |
( |
) | ||
|
|
|||
Net cash used in investing activities |
( |
) | ||
|
|
|||
CASH FLOW FROM FINANCING ACTIVITIES |
||||
Proceeds from sale of Units, net of underwriting discounts paid |
||||
Proceeds from sale of Private Placement Warrants |
||||
Repayment of note payable – related party |
( |
) | ||
Payment of offering costs |
( |
) | ||
|
|
|||
Net cash provided by financing activities |
||||
|
|
|||
NET CHANGE IN CASH |
||||
CASH, BEGINNING OF PERIOD |
||||
|
|
|||
CASH, END OF PERIOD |
$ | |||
|
|
|||
SUPPLEMENTAL DISCLOSURES OF NONCASH ACTIVITIES |
||||
Initial classification of derivative warrant liability |
$ | |||
Initial classification of derivative forward purchase agreement |
( |
) | ||
Initial value of common stock subject to possible redemption |
$ | |||
Deferred underwriting fees charged to additional paid in capital |
$ |
As previously reported |
Warrant liabilities adjustments |
Class A common stock subject to possible redemption adjustments |
As Restated |
|||||||||||||
Balance Sheet as of February 2, 2021 (audited) |
||||||||||||||||
Derivative warrant liabilities |
$ | — | $ | $ |
— |
$ |
||||||||||
Derivative forward purchase agreement liability |
$ | — | $ | $ |
— |
$ |
||||||||||
Total liabilities |
$ | $ | $ |
— |
$ |
|||||||||||
Class A common stock subject to redemption |
$ | $ | ( |
) | $ |
$ | ||||||||||
Class A Common stock |
$ | $ | $ |
( |
) |
$ | — | |||||||||
Additional paid-in capital |
$ | $ | $ |
( |
) |
$ | — | |||||||||
Accumulated deficit |
$ | ( |
) | $ | ( |
) | $ |
( |
) |
$ | ( |
) | ||||
Total Stockholders’ Equity |
$ | $ | ( |
) | $ |
( |
) |
$ | ( |
) | ||||||
Shares of Class A common stock subject to redemption |
( |
) | ||||||||||||||
Shares of Class A Common stock |
( |
) |
— | |||||||||||||
Balance Sheet as of March 31, 2021 (unaudited) |
||||||||||||||||
Class A common stock subject to redemption |
$ | $ | $ |
$ | ||||||||||||
Class A Common stock |
$ | $ | $ |
( |
) |
$ | — | |||||||||
Additional paid-in capital |
$ | — | $ | — | $ |
— |
$ | — | ||||||||
Retained Earnings (Accumulated deficit) |
$ | $ | $ |
( |
) |
$ | ( |
) | ||||||||
Total Stockholders’ Equity |
$ | $ | $ |
( |
) |
$ | ( |
) | ||||||||
Shares of Class A common stock subject to redemption |
||||||||||||||||
Shares of Class A Common stock |
( |
) |
— | |||||||||||||
Statement of Operations for the three months ended March 31, 2021 |
||||||||||||||||
Basic and diluted Class A weighted-average shares outstanding |
( |
) |
||||||||||||||
Basic and diluted Class A net income (loss) per share |
$ | — | $ | $ |
$ | |||||||||||
Basic and diluted Class B weighted-average shares outstanding |
( |
) |
||||||||||||||
Basic and diluted Class B net income (loss) per share |
$ | $ | $ |
( |
) |
$ | ||||||||||
Statement of cashflows for the three months ended March 31, 2021 (unaudited) |
||||||||||||||||
SUPPLEMENTAL DISCLOSURES OF NONCASH ACTIVITIES |
||||||||||||||||
Initial classification of common stock subject to redemption |
$ | $ | $ |
$ | ||||||||||||
Change in value of common stock subject to possible redemption |
$ | ( |
) | $ | $ |
$ | — | |||||||||
Statement of changes in stockholders equity for the three months ended March 31, 2021 (unaudited) |
||||||||||||||||
Sale of units in initial public offering, net of offering costs and initial fair value of public warrants |
$ | $ | — | $ | ( |
) | $ | — | ||||||||
Initial classification of common stock subject to possible redemption |
$ | ( |
) | $ | — | $ | $ | — | ||||||||
Change in common stock subject to possible redemption |
$ | ( |
) | $ | — | $ | $ | — | ||||||||
Accretion of Class A common stock subject to possible redemption |
$ | — | $ | — | $ | ( |
) | $ | ( |
) |
Fair Value Measured as of March 31, 2021 |
||||||||||||
Level 1 |
Level 2 |
Level 3 |
||||||||||
Assets: |
||||||||||||
Investments held in Trust Account (1) |
$ | $ | — | $ | — | |||||||
Derivative forward purchase agreement (2) |
$ | — | $ | — | $ | |||||||
Liabilities: |
||||||||||||
Derivative warrant liabilities - Public Warrants (3) |
$ | $ | — | $ | — | |||||||
Derivative warrant liabilities - Private Placement Warrants (4) |
$ | — | $ | — | $ |
(1) | The fair value of the investments held in Trust Account was based on the quoted market price. |
(2) | The fair value of the derivative forward purchase agreement was based on the adjusted net assets method. |
(3) | The fair value of the derivative warrant liabilities – Public Warrants was based the quoted market price for MIT.W as of the reporting date. |
(4) | The fair value of the derivative warrant liabilities – Private Placement Warrants was based on a modified Black-Scholes model. |
February 2, 2021 (Initial Measurement) |
||||
Strike price |
$ | |||
Term (in years) |
||||
Risk-free rate |
% | |||
Volatility |
% | |||
Dividend yield |
% | |||
Fair value of Public Warrants |
$ | |||
Fair value of Private Placement Warrants |
$ |
March 31, 2021 |
||||
Strike price |
$ | |||
Term (in years) |
||||
Risk-free rate |
% | |||
Volatility |
% | |||
Dividend yield |
% | |||
Fair value of Private Placement Warrants |
$ |
• | Term – the expected life of the warrants was assumed to be equivalent to their remaining contractual term. |
• | Risk-free rate – the risk-free interest rate is based on the U.S. Treasury yield curve in effect on the date of valuation equal to the remaining expected life of the Warrants. |
• | Volatility – the Company estimated the volatility of its common stock warrants based on implied volatility and actual historical volatility of a group of comparable publicly traded companies observed over a historical period equal to the expected remaining life of the Warrants. |
• | Dividend yield – the dividend yield percentage is zero because the Company does not currently pay dividends, nor does it intend to do so during the expected term of the Private Placement Warrants. |
Public Warrants |
Private Placement Warrants |
Total Derivative Warrant Liability |
||||||||||
Derivative warrant liabilities at December 31, 2020 |
$ | $ | $ | |||||||||
Issuance of Public and Private Warrants |
||||||||||||
Change in fair value of warrant liabilities |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Derivative warrant liabilities at March 31, 2021 |
$ | $ | $ | |||||||||
|
|
|
|
|
|
FPA Asset (Liability) |
||||
Derivative forward purchase agreement at December 31, 2020 |
$ | |||
Executed forward purchase agreement in connection with IPO |
( |
) | ||
Change in fair value of the derivative forward purchase agreement |
||||
|
|
|||
Derivative forward purchase agreement at March 31, 2021 |
$ | |||
|
|
• | in whole and not in part; |
• | at a price of $ |
• | at any time during the exercise period; |
• | upon a minimum of |
• | if, and only if, the last sale price of the Company’s Class A common stock equals or exceeds $ |
• | If, and only if, there is a current registration statement in effect with respect to the shares of Class A common stock underlying such warrants. |
Three Months Ended March 31, 2021 |
||||||||
Class A |
Class B |
|||||||
Basic and diluted net loss per share |
||||||||
Numerator |
||||||||
Allocation of net income |
$ | $ | ||||||
|
|
|
|
|||||
Denominator |
||||||||
Weighted-average shares outstanding |
||||||||
Basic and diluted net income per share |
$ | $ |
Gross Proceeds |
$ |
|||
Less: |
||||
Offering costs and underwriting fees allocated to Class A common stock subject to possible redemption |
( |
) | ||
Proceeds allocated to Public Warrants at issuance |
( |
) | ||
Plus: |
||||
Accretion on Class A common stock subject to possible redemption amount |
||||
|
|
|||
Class A common stock subject to possible redemption |
$ |
|||
|
|
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk |
Item 4. |
Controls and Procedures |
Item 1. |
Legal Proceedings |
Item 1A. |
Risk Factors. |
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds |
Item 3. |
Defaults Upon Senior Securities |
Item 4. |
Mine Safety Disclosures |
Item 5. |
Other Information |
Item 6. |
Exhibits. |
* | Filed herewith. |
** | Furnished. |
MASON INDUSTRIAL TECHNOLOGY, INC. |
Date: December 8, 2021 | By: | /s/ Derek Satzinger | ||||
Name: Derek Satzinger | ||||||
Title: Chief Financial Officer |